In 2002, the International Agency for Research on Cancer Handbook on Weight Control and Physical Activity concluded that overweight and obesity are related to cancers of the colon, endometrium, kidney and oesophagus (adenocarcinomas), as well as postmenopausal breast cancer. Since that report, continuing epidemiological investigation has suggested that other cancers are related to obesity and overweight. In addition to those listed above, the report by the World Cancer Research Fund (WCRF) Panel on Food, Nutrition, Physical Activity, and the Prevention of Cancer ([@bib16]) considered that there was convincing evidence for an association with cancers of the pancreas and rectum (as well as colon), and a probable association with cancers of the gall bladder. The fraction of these cancers occurring in 2010 attributable to overweight and obesity in the UK population is estimated in this section.

Methods
=======

The estimates of risk associated with overweight (BMI 25\<30 kg m^−2^) and obesity (BMI 30+ kg m^−2^), relative to a BMI⩽25 kg m^−2^, for the seven cancers, are shown in [Table 1](#tbl1){ref-type="table"}. The estimates of relative risk for an increase of 5 kg m^−2^ from the meta-analyses by [@bib16] have been used for the category 'overweight\'. Assuming a constant rate of increase in risk with BMI, the square of this value was taken for the category 'obese\'. For postmenopausal breast cancer, WCRF reported that the increase in risk was 8% per BMI increase of 5 kg m^−2^ for cohort studies (17 considered) and 13% per BMI increase of 5 kg m^−2^ for case--control studies (48 considered). The estimates from the meta-analyses of [@bib2] and [@bib13] were almost identical (12% per BMI increase of 5 kg m^−2^), and thus this value has been selected.

The latent period, or interval between 'exposure\' to overweight/obesity and the appropriate increase in risk of these cancers, is not known. [@bib13] calculated the geometric mean duration of follow-up in the cohort studies available for a meta-analysis of relative risks due to overweight and obesity. The periods ranged from 8.4 years (for breast cancer) to 12.7 years (for gall bladder cancer). We therefore chose to assume that the latency between 'exposure\' and outcome would be, on average, 10 years, and thus examine the effects on cancers occurring in 2010 from suboptimal levels of body mass in 2000. The proportion of adults in the age group of 19--64 who were overweight or obese in Great Britain in 2000--2001 is available from the [@bib5]; Table 4.1). For older adults (aged ⩾65), we used the values for 2000 from the Health Survey for England ([@bib6]). The results are shown in [Table 2](#tbl2){ref-type="table"}.

The number of oesophageal cancers diagnosed in 2010 was partitioned by histological subtype, according to the age- and sex-specific distribution observed in the UK Cancer registries reporting to Cancer Incidence in Five Continents, Volume VIII ([@bib10]). These age-specific proportions were scaled to correspond to the crude proportions observed in the UK registries in 2000--2002 ([@bib4]), when adenocarcinomas comprised 69.9% of oesophageal cancers in men and 39.9% in women.

The population-attributable fraction (PAF) was calculated for each sex--age group, corresponding to the level of overweight/obesity 10 years previously, according to the usual formula:

where *p*~1~ is the proportion of population overweight, *p*~2~ the proportion of population obese, ERR~1~ the excess relative risk (RR−1) for overweight and ERR~2~ the excess relative risk (RR−1) for obesity.

Results
=======

[Table 3](#tbl3){ref-type="table"} shows the calculation of attributable fractions, and corresponding numbers of attributable cases, by age group and sex, for seven cancer types accepted to be causally related to excess body weight, assuming a 10-year latency between the presence of excess body mass and cancer risk.

[Table 4](#tbl4){ref-type="table"} summarises these results. An estimated 17 294 excess in cancer cases occurring in 2010 were due to overweight and obesity (5.5% of all cancers). The sites contributing most to this excess are large bowel (5172) and breast (4194).

Discussion
==========

The list of cancers that have been selected as being related to excess body mass (overweight and obesity) is a conservative one. It corresponds to those in the consensus statements of [@bib7] and [@bib16]. Needless to say, other studies have identified a large number of other cancers to be associated with excess body mass. In the recent meta-analysis of prospective studies (cohort studies and clinical trials) by [@bib13], there was a positive (statistically significant) association between BMI and cancer of the thyroid, leukaemia, malignant melanoma (men only), non-Hodgkin lymphoma and multiple myeloma. Others have reported significant associations with cancers of the prostate ([@bib2]), ovary ([@bib11]; [@bib14]; [@bib8]) and brain ([@bib1]), as well as cancers of the liver ([@bib9]) and gastric cardia ([@bib3]).

In common with most reviews, we have chosen to ignore possible differences in risk between men and women, although for some cancers -- especially colorectal cancers -- a greater effect in men than in women is found in some studies ([@bib3]; [@bib13]) but not others ([@bib2]).

The 10-year 'latency\' used to define the relevant time period at which to measure population prevalence of overweight and obesity is somewhat arbitrary. It was based on the average period of follow-up in the large cohort studies from which the estimates of relative risk are derived (as reported by [@bib13]).

Several previous estimates of the fraction of cancer in the UK attributable to overweight and obesity have been published. [@bib2] considered a similar range of cancers to those in this paper, but included cancers of the prostate as related to BMI, and excluded oesophageal adenocarcinoma; based on relative risks from their own meta-analyses, they estimated that 2.7% of cancers diagnosed in men and 4.9% in women in the UK in 1995 were related to overweight/obesity during 1983--6. [@bib12] include a much wider range of cancers, as noted earlier, based on their meta-analysis of 2008 ([@bib13]); their estimate of attributable fraction (for 2002, based on overweight/obesity (single category) in 1992 (from WHO)) was 4.01% in women and 3.42% in men. [@bib11] used the results of the Million Women Study to estimate that 5% of cancers in postmenopausal women in 2004 were related to overweight and obesity (based on prevalence in England in the same year), and including nine cancers observed to have a significant trend of increasing risk with increasing BMI (including leukaemia, ovary, multiple myeloma and non-Hodgkin lymphoma, but excluding colorectal cancers). The estimate of the proportion of cancers related to 'body fatness\' in the UK in 2002 by [@bib15] is given only for the seven sites analysed in this paper: 18% of the five cancers in men and 16% of the seven in women. This would be equivalent to an overall AF (for all cancers) of 4.2% in men and 8.7% in women. There are several reasons for this larger estimate. WCRF selected 'representative\' studies from which to take the relative risks -- almost all are in excess of the pooled values from their own meta-analyses. Exposure prevalence was taken from data for the same year as outcome (2002); exposure prevalence would have been lower if prevalence at an earlier period had been used, given the continuously rising trend of overweight and obesity in recent years. Finally, the baseline category (not overweight or obese) was not always ⩽25 kg m^−2^, but for some cancers (breast and pancreas) it was ⩽23 kg m^−2^.
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###### Relative risks associated with overweight and obesity

                                                                 **Relative risks**   **Excess relative risks**          
  -------------------------------------------------------------- -------------------- --------------------------- ------ ------
  Breast (post-menopausal)[a,b](#t1-fn1 t1-fn2){ref-type="fn"}   1.12                 1.25                        0.12   0.25
  Colorectum[c](#t1-fn3){ref-type="fn"}                          1.15                 1.32                        0.15   0.32
  Oesophagus (adenocarcinoma)[c](#t1-fn3){ref-type="fn"}         1.55                 2.40                        0.55   1.40
  Kidney[c](#t1-fn3){ref-type="fn"}                              1.31                 1.72                        0.31   0.72
  Endometrium[c](#t1-fn3){ref-type="fn"}                         1.52                 2.31                        0.52   1.31
  Gall bladder[c](#t1-fn3){ref-type="fn"}                        1.23                 1.51                        0.23   0.51
  Pancreas[c](#t1-fn3){ref-type="fn"}                            1.14                 1.30                        0.14   0.30

From [@bib2].

From [@bib13].

From [@bib16].

###### Prevalence of overweight and obesity in Great Britain in 2000--2001

                         **Prevalence of overweight and obesity by age group (years)**                               
  ---------------------- --------------------------------------------------------------- ------ ------ ------ ------ ------
  *Men*                                                                                                              
   25\<30 (overweight)   0.25                                                            0.42   0.45   0.46   0.50   0.52
   ⩾30 (obese)           0.18                                                            0.18   0.25   0.32   0.24   0.17
                                                                                                                      
  *Women*                                                                                                            
   25\<30 (overweight)   0.25                                                            0.28   0.31   0.41   0.41   0.41
   ⩾30 (obese)           0.14                                                            0.16   0.23   0.22   0.30   0.23

Abbreviations: BMI=body mass index.

From the National Diet and Nutrition Survey (ages 19--64).

From Health Survey for England (ages \>65).

###### Cancer cases diagnosed in 2010 attributable to overweight and obesity in 2000

                               **Cases attributable to obesity for each cancer**                                                                                                                                                                                                  
  ----------- -------- ------ --------------------------------------------------- ------ ------ -------------- ------ ----- ------------- ------ ------ -------------- ------ -------- --------------- ------ -------- -------------- ------ ------ --------------- ------ ------ ---------------
  *Men*                                                                                                                                                                                                                                                                           
   19--24      25--34   0.25                         0.18                          0.28    4          1         0.13    0        0.0       0.08    9         0.7        0.09    133         11.6                                                                     0.17    31         5.3
   24--34      35--44   0.42                         0.18                          0.33    27         9         0.16    1        0.2       0.10    67        6.8        0.11    397         42.9                                                                     0.21   206        42.4
   35--49      45--59   0.45                         0.25                          0.37   358        134        0.19   24        4.5       0.12   587        71.1       0.13    2921        376.9                                                                    0.24   1142       275.9
   50--64      60--74   0.46                         0.32                          0.41   1405       579        0.21   83       17.6       0.14   1771      244.6       0.15    9481       1392.8                                                                    0.27   2368       641.7
   65--74      75--84   0.50                         0.24                          0.38   963        589        0.19   59       11.5       0.13   1188      149.2       0.13    6774        905.6                                                                    0.25   1418       352.7
   ⩾75          ⩾85     0.52                         0.17                          0.34   371        227        0.17   22        3.8       0.11   460        50.6       0.12    2388        279.7                                                                    0.22   472        104.0
  Total (%)             ---                           ---                          ---    5713   1538 (26.9)           191   37.5 (19.7)          4084   523.1 (12.8)          22 127   3009.4 (13.6)                                                                       5697   1422.0 (25.0)
                                                                                                                                                                                                                                                                                          
  *Women*                                                                                                                                                                                                                                                                         
   19--24      25--34   0.25                         0.14                          0.25    1         0.2        0.11    1        0.1       0.07    11        0.8        0.08    136         10.2        0.00    634         0.0        0.24    38         9.0        0.15    29         4.3
   24--34      35--44   0.28                         0.16                          0.27    4         1.2        0.13    8        1.0       0.08    53        4.2        0.09    402         34.4        0.00    4012        0.0        0.26   211        55.3        0.17   110        18.4
   35--49      45--59   0.31                         0.23                          0.33    50        16.5       0.16   73       11.6       0.10   437        44.1       0.11    2292        246.8       0.09   15 203      1328.0      0.32   1926       609.2       0.21   554        114.6
   50--64      60--74   0.41                         0.22                          0.35   267        93.0       0.17   198      34.0       0.11   1520      166.9       0.12    6116        715.3       0.10   18 120      1724.3      0.33   3844      1283.9       0.22   1275       282.5
   65--74      75--84   0.41                         0.30                          0.39   320       125.9       0.20   143      28.6       0.13   1374      177.4       0.14    5527        759.3       0.11    7855       881.0       0.38   1570       594.8       0.26   903        231.2
   ⩾75          ⩾85     0.41                         0.23                          0.36   220        78.5       0.18   86       15.2       0.11   884       100.2       0.12    3283        396.3       0.10    4410       433.4       0.34   605        207.2       0.23   428        97.6
  Total (%)             ---                           ---                                 2819   315.3 (11.2)          509   90.5 (17.8)          4280   493.6 (11.5)          17 787   2162.4 (12.2)          48 385   4366.7 (9.0)          8195   2759.3 (33.7)          3365   748.6 (22.2)
                                                                                                                                                                                                                                                                                          
  *Persons*                                                                                                                                                                                                                                                                       
   19--24      25--34   ---                          *---*                                 0         1.2                1        0.1               20        1.5                269         21.8                634         0.0                38         9.0                60         9.6
   24--34      35--44   ---                          *---*                                 31        10.0               9        1.2              120        11.0               799         77.3                4012        0.0               211        55.3               316        60.8
   35--49      45--59   ---                          *---*                                408       150.4              97       16.1              1024      115.3               5213        623.7              15 203      1328.0             1926       609.2              1696       390.5
   50--64      60--74   ---                          *---*                                1672      672.4              281      51.6              3291      411.5              15 597      2108.1              18 120      1724.3             3844      1283.9              3643       924.2
   65--74      75--84   ---                          *---*                                1283      714.4              202      40.0              2562      326.6              12 301      1664.9               7855       881.0              1570       594.8              2321          
   ⩾75          ⩾85     ---                          *---*                                591       305.1              108      19.0              1344      150.8               5671                            4410                          605        207.2              900           
  Total (%)             ---                           ---                                 8532   1853 (21.7)           700   128 (18.3)           8364   1017 (12.2)           39 914    5172 (13.0)           48 385    4367 (9.0)           8195    2759 (33.7)           9062    2171 (24.0)

Abbreviations: Obs=observed cases; PAF=population-attributable fraction.

Observed cases are for adenocarcinoma only.

Total observed cases (and percentages) are for all oesophageal cancers, and so are greater than the sum of observed cases.

###### Numbers and proportion of cases occurring at selected sites attributable to overweight and obesity (UK 2010)

                   **Excess attributable cases (PAF)**                  
  ---------------- ------------------------------------- -------------- --------------
  Oesophagus       1538 (26.9)                           315 (11.2)     1853 (21.7)
  Gallbladder      381 (9.7)                             91 (17.8)      128 (18.3)
  Pancreas         523 (12.8)                            494 (11.5)     1017 (12.2)
  Colorectum       3009 (13.6)                           2162 (12.2)    5172 (13.0)
  Breast           ---                                   4194 (8.7)     4194 (8.7)
  Endometrium      ---                                   2759 (33.7)    2759 (33.7)
  Kidney           1422 (25.0)                           749 (22.2)     2171 (24.0)
                                                                         
  All cancers^a^   6530 (4.1)                            10 764 (6.9)   17 294 (5.5)

Abbreviations: PAF=population-attributable fraction (%).

Excluding non-melanoma skin cancer.
